Ruth Lehman Wiens
Family Medicine · West St Paul, MNNPI 1861921611
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $577 and has fallen 88.4% since, to $67 in 2025. Among family medicine clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $14.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$261
- Amgen$180
- Lilly USA, LLC$171
- Kowa Pharmaceuticals America, Inc.$92
- Amarin Pharma, Inc.$84
- Biohaven Pharmaceutical Holding Company Ltd.$56
- plus $561 from 22 others
What the payments were for
- Food & beverage$1,406100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,406 in reported general payments places this provider in the 95th percentile of 1,162 family medicine providers in Minnesota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 109 | $75,181 |
| EliquisApixaban | 80 | $48,055 |
| TrulicityDulaglutide | 30 | $45,973 |
| FarxigaDapagliflozin Propanediol | 15 | $17,906 |
| EntrestoSacubitril/Valsartan | 22 | $14,891 |
| MyrbetriqMirabegron | 25 | $13,377 |
| OzempicSemaglutide | 15 | $13,243 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $12,291 |
| XareltoRivaroxaban | 22 | $12,250 |
| Breo ElliptaFluticasone/Vilanterol | 32 | $12,014 |
| Spiriva RespimatTiotropium Bromide | 15 | $7,683 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,849 |
| Atorvastatin Calcium | 436 | $2,475 |
| Risperidone OdtRisperidone | 13 | $2,347 |
| Levothyroxine Sodium | 308 | $2,249 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat | $29 | $82,864124 claims |
| Lilly USA, LLCTrulicity | $171 | $45,97330 claims |
| AstraZenecaFarxiga | $24 | $17,90615 claims |
| NovartisEntresto | $44 | $14,89122 claims |
| Astellas Pharma US IncMyrbetriq | $27 | $13,37725 claims |
| Novo NordiskOzempic | $38 | $13,24315 claims |
| Johnson & JohnsonXarelto | $23 | $12,25022 claims |
| AbbVieSynthroid | $261 | $1,58623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,162 family medicine providers in Minnesota.
Other family medicine in West St Paul
- Amanda LovoldSt Cloud$387K
- Robert MarshMinnetonka$300K
- Taylor MertzMoorhead$176K
- Justin YoungTracy$93K
- Gerard SpoelhofDuluth$75K
- Martha MasciopintoCottage Grove$50K
- Glenn DetlefsenRosemount$39K
- Amy GilbertSaint Paul$27K
- Kevin PetersonMinneapolis$25K
- Joseph McGrathWabasha$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.